Free Trial

InMode (INMD) Competitors

InMode logo
$15.44 +0.34 (+2.25%)
As of 01:40 PM Eastern

INMD vs. NVST, PRCT, LIVN, WRBY, NVCR, LMAT, EYE, ENOV, CNMD, and AORT

Should you be buying InMode stock or one of its competitors? The main competitors of InMode include Envista (NVST), PROCEPT BioRobotics (PRCT), LivaNova (LIVN), Warby Parker (WRBY), NovoCure (NVCR), LeMaitre Vascular (LMAT), National Vision (EYE), Enovis (ENOV), CONMED (CNMD), and Artivion (AORT). These companies are all part of the "medical equipment" industry.

InMode vs. Its Competitors

Envista (NYSE:NVST) and InMode (NASDAQ:INMD) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, earnings, analyst recommendations, media sentiment, institutional ownership, dividends, risk and profitability.

InMode has a net margin of 44.79% compared to Envista's net margin of -44.90%. InMode's return on equity of 17.17% beat Envista's return on equity.

Company Net Margins Return on Equity Return on Assets
Envista-44.90% 4.07% 2.25%
InMode 44.79%17.17%15.20%

Envista has a beta of 1, meaning that its stock price has a similar volatility profile to the S&P 500.Comparatively, InMode has a beta of 1.95, meaning that its stock price is 95% more volatile than the S&P 500.

InMode has lower revenue, but higher earnings than Envista. Envista is trading at a lower price-to-earnings ratio than InMode, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Envista$2.51B1.36-$1.12B-$6.53-3.09
InMode$392.41M2.49$181.27M$2.336.63

In the previous week, Envista had 4 more articles in the media than InMode. MarketBeat recorded 6 mentions for Envista and 2 mentions for InMode. InMode's average media sentiment score of 1.59 beat Envista's score of 0.86 indicating that InMode is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Envista
3 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
InMode
2 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

68.0% of InMode shares are held by institutional investors. 1.3% of Envista shares are held by company insiders. Comparatively, 6.9% of InMode shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Envista presently has a consensus target price of $20.23, suggesting a potential upside of 0.35%. InMode has a consensus target price of $18.54, suggesting a potential upside of 20.09%. Given InMode's higher possible upside, analysts plainly believe InMode is more favorable than Envista.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Envista
1 Sell rating(s)
9 Hold rating(s)
4 Buy rating(s)
1 Strong Buy rating(s)
2.33
InMode
0 Sell rating(s)
7 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.13

Summary

InMode beats Envista on 12 of the 17 factors compared between the two stocks.

Get InMode News Delivered to You Automatically

Sign up to receive the latest news and ratings for INMD and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding INMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

INMD vs. The Competition

MetricInModeMED PRODUCTS IndustryMedical SectorNASDAQ Exchange
Market Cap$975.95M$10.35B$5.49B$8.93B
Dividend YieldN/A2.07%5.24%4.04%
P/E Ratio6.6316.9227.1520.17
Price / Sales2.4928.60380.3794.17
Price / Cash8.3123.9726.2128.59
Price / Book1.533.677.995.60
Net Income$181.27M$235.43M$3.17B$248.41M
7 Day Performance4.11%1.06%3.51%6.03%
1 Month Performance9.04%0.88%2.80%7.70%
1 Year Performance-11.32%-9.90%34.00%20.86%

InMode Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
INMD
InMode
3.321 of 5 stars
$15.44
+2.3%
$18.54
+20.1%
-13.1%$975.95M$392.41M6.63480
NVST
Envista
3.7054 of 5 stars
$19.58
-0.5%
$20.23
+3.3%
+19.8%$3.32B$2.51B-3.0012,300
PRCT
PROCEPT BioRobotics
2.2058 of 5 stars
$57.60
+1.2%
$90.00
+56.3%
-11.9%$3.19B$224.50M-33.88430News Coverage
Analyst Forecast
LIVN
LivaNova
3.2121 of 5 stars
$45.02
-1.6%
$59.29
+31.7%
-13.1%$2.45B$1.25B-11.012,900Positive News
WRBY
Warby Parker
2.183 of 5 stars
$21.94
+0.2%
$22.88
+4.3%
+36.1%$2.29B$771.32M-182.833,780Positive News
NVCR
NovoCure
3.7133 of 5 stars
$17.80
-1.1%
$32.83
+84.5%
+0.7%$1.98B$605.22M-11.791,488Analyst Forecast
LMAT
LeMaitre Vascular
2.4355 of 5 stars
$83.05
+0.6%
$97.83
+17.8%
-0.2%$1.88B$219.86M41.94490
EYE
National Vision
2.4831 of 5 stars
$23.01
-0.7%
$18.67
-18.9%
+90.3%$1.82B$1.85B-69.7313,411Analyst Forecast
Gap Up
ENOV
Enovis
3.5625 of 5 stars
$31.36
-1.3%
$58.00
+84.9%
-26.3%$1.79B$2.11B-2.257,367Positive News
Analyst Forecast
CNMD
CONMED
4.6239 of 5 stars
$52.10
-0.1%
$62.20
+19.4%
-24.7%$1.61B$1.31B13.713,900News Coverage
AORT
Artivion
2.7826 of 5 stars
$31.17
-0.1%
$32.00
+2.7%
+19.6%$1.33B$388.54M-62.341,600

Related Companies and Tools


This page (NASDAQ:INMD) was last updated on 7/8/2025 by MarketBeat.com Staff
From Our Partners